Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Will AstraZeneca plc’s Acquisition Spree Help The Company Return To Growth?

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) is snapping up smaller peers to drive growth but will this strategy work?

Read more »

Investing Articles

Why I’d Sell AstraZeneca plc And Buy Shire PLC

| Rupert Hargreaves

Shire PLC (LON: SHP) is a better bet than AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

How Pfizer Inc. Could Push AstraZeneca plc Down To 3,100p

| Alessandro Pasetti

AstraZeneca plc (LON:AZN) is a volatile business that will disappoint shareholders if Pfizer Inc. (NYSE:PFE) doesn't make a comeback, argues…

Read more »

Investing Videos

Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 Down?

| Owain Bennallack

VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) under the spotlight.

Read more »

Investing Articles

Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement AstraZeneca plc In Your Portfolio!

| Peter Stephens

Shire PLC (LON: SHP), Hikma Pharmaceuticals Plc (LON: HIK), BTG plc (LON: BTG) and AstraZeneca plc (LON: AZN) could have…

Read more »

Investing Articles

How Much Lower Can Shire PLC Go?

| Rupert Hargreaves

Shire PLC (LON: SHP) and AstraZeneca plc (LON:AZN) could fall further now mergers are off the table.

Read more »

Investing Articles

Why Smith & Nephew plc’s Latest Failure Should Worry AstraZeneca plc And GlaxoSmithKline plc

| Royston Wild

Royston Wild explains how Smith and Nephew plc (LON: SN)'s latest testing woes underlines the precarious nature of drugs testing

Read more »

Investing Articles

Why I’d Still Buy AstraZeneca plc Despite Shire PLC Deal Collapse

| Peter Stephens

AstraZeneca plc (LON: AZN) still looks hugely attractive – even after the collapse of AbbVie’s Shire PLC (LON: SHP) takeover

Read more »

Investing Articles

What Happens If Pfizer Inc. Doesn’t Come Back For AstraZeneca plc?

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) could fall if Pfizer doesn't return -- GlaxoSmithKline plc (LON: GSK) is a better choice, this…

Read more »

Investing Articles

GlaxoSmithKline PLC vs AstraZeneca PLC: Which Is The Better Dividend Play?

| Prabhat Sakya

Is GlaxoSmithKline plc (LON:GSK) or AstraZeneca plc (LON: AZN) the better high-yield play?

Read more »

Investing Articles

Will AstraZeneca plc Take The Hatchet To Its Dividend?

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) may have to slash shareholder payments.

Read more »

Investing Articles

Is AstraZeneca plc A Promising Capital-Growth Investment?

| Kevin Godbold

Some firms' growth is more sustainable than others. What about AstraZeneca plc (LON: AZN)?

Read more »